Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Case Report: A Severe SARS-CoV-2 Infection in a Teenager With Angelman Syndrome

Full text
Author(s):
Show less -
Lopes, Alessandra G. D. [1] ; Celestino, Camila S. H. [1] ; Barros, Tiago T. A. [2, 1] ; Fevereiro, Aline G. [1] ; Gejer, Debora H. [1] ; Oliveira, Fernando M. F. [1] ; Brasil, Jamile M. [1] ; Bossolan, Rosely M. [1] ; Pinto, Gabriela C. C. [1] ; Santos, Ana C. E. Z. [1] ; Divan, Luis A. [1] ; Alves, Ingrid A. B. [1] ; Oliveira, Danielle B. L. [3, 4] ; Machado, Rafael R. G. [3] ; Thomazelli, Luciano M. [3] ; Hiyane, Meire I. [5] ; Brelaz-Abreu, Leonilia [2] ; Braganca-Jardim, Elayne [2] ; Heinen, Leticia B. S. [2] ; Barrientos, Anna C. M. [1] ; Mau, Luciana B. [1] ; Camara, Niels O. S. [5] ; Bueno, Daniela F. [2, 1] ; Amano, Mariane T. [2]
Total Authors: 24
Affiliation:
[1] Hosp Municipal Infantil Menino Jesus, Sao Paulo - Brazil
[2] Hosp Sirio Libanes, Sao Paulo - Brazil
[3] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo - Brazil
[4] Hosp Israelita Albert Einstein, Sao Paulo - Brazil
[5] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Sao Paulo - Brazil
Total Affiliations: 5
Document type: Journal article
Source: FRONTIERS IN MEDICINE; v. 8, MAR 12 2021.
Web of Science Citations: 0
Abstract

Teenagers generally present mild to no symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In the present report, we present the case of a 14-year-old boy with Angelman syndrome (AS) who presented with severe COVID-19 symptoms. He spent 20 days in the ICU with elevated inflammatory biomarkers (C-reactive protein and D-dimer) and increased peaks of neutrophil-to-lymphocyte ratio, which is uncommon for teenagers diagnosed with COVID-19. Although he showed physiological instability, he was able to produce neutralizing antibodies, suggesting a functional immune response. The literature concerning the immune response to infections in patients with AS is still poor, and to our knowledge, this was the first report of a patient with AS diagnosed with COVID-19. As such, the present study may alert other patients with AS or other rare diseases that they lack a competent immune response and could suffer severe consequences of SARS-CoV-2 infection. (AU)

FAPESP's process: 17/24769-2 - Zika virus in postpartum women and newborns: seroepidemiology and molecular characterization
Grantee:Rafael Rahal Guaragna Machado
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 20/06409-1 - Evaluation of humoral immune response and inflammatory response in patients with confirmed diagnosis of COVID-19 at Hospital Sírio Libanês and correlation with disease severity
Grantee:Edison Luiz Durigon
Support Opportunities: Regular Research Grants